What changed 10-Q

Item 5. Other Information

2022-11-09 compared with 2022-07-27 · 3 added, 3 removed, 48 unchanged (11% of the section changed)

22 unchanged sentences

1 to the Investor Rights Agreement, dated May 23, 2022, by and among Innoviva, Inc.

and Entasas Therapeutics Holdings Inc

and Entasis Therapeutics Holdings Inc.

Support Agreement, dated July 10, 2022, by and among Innoviva, Inc., Innoviva Acquisition Sub, Inc., Tang Capital Partners, LP and Kevin C.

15 unchanged sentences

Innoviva, Inc.

July 27, 2022

November 09, 2022

/s/ Pavel Raifeld

2 unchanged sentences

(Principal Executive Officer)

July 27, 2022

November 09, 2022

/s/ Marianne Zhen

3 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.